Lois Jovanovic

Summary

Publications

  1. ncbi request reprint Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone
    Lois Jovanovic
    Sansum Medical Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Diabetes Res Clin Pract 63:127-34. 2004
  2. pmc Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events
    Benyamin Grosman
    Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 4:961-75. 2010
  3. pmc Experimental evaluation of a recursive model identification technique for type 1 diabetes
    Daniel A Finan
    Department of Chemical Engineering, University of California, Santa Barbara, California, USA
    J Diabetes Sci Technol 3:1192-202. 2009
  4. pmc A novel adaptive basal therapy based on the value and rate of change of blood glucose
    Youqing Wang
    Department of Chemical Engineering, University of California, Santa Barbara, California, USA
    J Diabetes Sci Technol 3:1099-108. 2009
  5. pmc Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm
    Howard Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California, USA
    J Diabetes Sci Technol 3:487-91. 2009
  6. pmc Predicting subcutaneous glucose concentration using a latent-variable-based statistical method for type 1 diabetes mellitus
    Chunhui Zhao
    Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 6:617-33. 2012
  7. pmc Clinically relevant hypoglycemia prediction metrics for event mitigation
    Rebecca A Harvey
    Sansum Diabetes Research Institute, Santa Barbara, CA 93106, USA
    Diabetes Technol Ther 14:719-27. 2012
  8. pmc Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia--monitor, alert, and locate
    Eyal Dassau
    Department of Chemical Engineering, University of California at Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 3:1501-6. 2009
  9. pmc Modeling the effects of subcutaneous insulin administration and carbohydrate consumption on blood glucose
    Matthew W Percival
    Department of Chemical Engineering, University of California, Santa Barbara, CA 93106 5080, USA
    J Diabetes Sci Technol 4:1214-28. 2010
  10. doi request reprint Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell
    Youqing Wang
    Department of Chemical Engineering, University of California Santa Barbara, Santa Barbara, CA 93106, USA
    Diabetes Technol Ther 12:879-87. 2010

Collaborators

Detail Information

Publications70

  1. ncbi request reprint Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone
    Lois Jovanovic
    Sansum Medical Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Diabetes Res Clin Pract 63:127-34. 2004
    ..In summary, for patients who had previously failed oral antidiabetic monotherapy, the combination repaglinide/pioglitazone had acceptable safety, with greater reductions of glycemic parameters than therapy using either agent alone...
  2. pmc Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events
    Benyamin Grosman
    Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 4:961-75. 2010
    ....
  3. pmc Experimental evaluation of a recursive model identification technique for type 1 diabetes
    Daniel A Finan
    Department of Chemical Engineering, University of California, Santa Barbara, California, USA
    J Diabetes Sci Technol 3:1192-202. 2009
    ..Such an adaptive strategy will ensure that the most accurate model is used for the current conditions, and thus the most accurate model predictions are used in model-based control calculations...
  4. pmc A novel adaptive basal therapy based on the value and rate of change of blood glucose
    Youqing Wang
    Department of Chemical Engineering, University of California, Santa Barbara, California, USA
    J Diabetes Sci Technol 3:1099-108. 2009
    ..New insulin pumps could receive a direct feed of glucose values from a continuous glucose monitoring (CGM) system and could enable dynamic basal adaptation to improve glycemic control...
  5. pmc Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm
    Howard Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California, USA
    J Diabetes Sci Technol 3:487-91. 2009
    ..The objective was to use a refined run-to-run algorithm to calculate prandial insulin-to-carbohydrate ratios (I:CHO) for meals of variable carbohydrate content in subjects with type 1 diabetes (T1DM)...
  6. pmc Predicting subcutaneous glucose concentration using a latent-variable-based statistical method for type 1 diabetes mellitus
    Chunhui Zhao
    Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 6:617-33. 2012
    ..The availability of frequent glucose measurements, insulin infusion rates, and meal carbohydrate estimates can be used to good advantage to capture important information concerning glucose dynamics...
  7. pmc Clinically relevant hypoglycemia prediction metrics for event mitigation
    Rebecca A Harvey
    Sansum Diabetes Research Institute, Santa Barbara, CA 93106, USA
    Diabetes Technol Ther 14:719-27. 2012
    ....
  8. pmc Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia--monitor, alert, and locate
    Eyal Dassau
    Department of Chemical Engineering, University of California at Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 3:1501-6. 2009
    ..In addition to providing a safety layer to a future artificial pancreas, this system also can be easily implemented in current continuous glucose monitors to help provide information and alerts to people with diabetes...
  9. pmc Modeling the effects of subcutaneous insulin administration and carbohydrate consumption on blood glucose
    Matthew W Percival
    Department of Chemical Engineering, University of California, Santa Barbara, CA 93106 5080, USA
    J Diabetes Sci Technol 4:1214-28. 2010
    ..The goal of this study was to quantify these effects in people with T1DM using a novel protocol...
  10. doi request reprint Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell
    Youqing Wang
    Department of Chemical Engineering, University of California Santa Barbara, Santa Barbara, CA 93106, USA
    Diabetes Technol Ther 12:879-87. 2010
    ..To conquer these challenges, an automatic bolus and adaptive basal (ABAB) therapy is proposed to regulate glucose levels for people with type 1 diabetes mellitus...
  11. pmc Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board
    Christian Ellingsen
    Department of Chemical Engineering, University of California at Santa Barbara, Santa Barbara, CA 93106 5080, USA
    J Diabetes Sci Technol 3:536-44. 2009
    ..The core of such a system is a control algorithm that calculates the insulin dose based on automated glucose measurements...
  12. ncbi request reprint Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique
    Wendy C Bevier
    Sansum Diabetes Research Institute, Santa Barbara, CA 93105, USA
    Diabetes Metab Res Rev 23:472-8. 2007
    ..We are presenting data for a novel use of the hyperinsulinaemic-euglycaemic clamp (HEC) in patients with type 1 diabetes that minimizes the impact of these variables and can be used to determine the I : C...
  13. pmc Design of the health monitoring system for the artificial pancreas: low glucose prediction module
    Rebecca A Harvey
    Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
    J Diabetes Sci Technol 6:1345-54. 2012
    ..Safe operation of the APDS is a critical task, where the safety system is engaged only as needed to ensure reliable operation without positive feedback to the controller...
  14. pmc Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas
    Eyal Dassau
    Department of Chemical Engineering, University of California Santa Barbara, Santa Barbara, California, USA
    Diabetes Care 33:1249-54. 2010
    ..This approach can provide a solution to the problem of nocturnal hypoglycemia, a major concern of patients with diabetes...
  15. ncbi request reprint Bolus calculator: a review of four "smart" insulin pumps
    Howard Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Diabetes Technol Ther 10:441-4. 2008
    ..It will also include an in silico simulation of a meal followed by a snack using multiple insulin decay curves...
  16. pmc Clinical evaluation of a personalized artificial pancreas
    Eyal Dassau
    Department of Chemical Engineering, University of California, Santa Barbara, California, USA
    Diabetes Care 36:801-9. 2013
    ..Such a device would prevent hypo- and hyperglycemia along with associated long- and short-term complications as well as ease some of the day-to-day burden of frequent blood glucose measurements and insulin administration...
  17. doi request reprint Insulin pumps in pregnancy: using technology to achieve normoglycemia in women with diabetes
    Kristin Castorino
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Curr Diab Rep 12:53-9. 2012
    ..In this review of the literature we focus on the use of insulin pumps in the management of diabetes in pregnancy...
  18. doi request reprint Continuous glucose monitoring during pregnancy
    Lironn Chitayat
    Sansum Diabetes Research Institute, University of California Santa Barbara, Santa Barbara, California 93105, USA
    Diabetes Technol Ther 11:S105-11. 2009
    ..Demarcation of the normal glucose profile that is present during gestation better defines the therapeutic goals for women with diabetes and ultimately promotes success in pregnancy...
  19. pmc In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control
    Justin J Lee
    Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California 93106 5080, USA
    J Diabetes Sci Technol 7:215-26. 2013
    ..Because of the slow pharmacokinetics of subcutaneous (SC) insulin, avoiding postprandial hyperglycemia has been a major challenge for an artificial pancreas (AP) using SC insulin without a meal announcement...
  20. ncbi request reprint Practical issues in the identification of empirical models from simulated type 1 diabetes data
    Daniel A Finan
    Department of Chemical Engineering, University of California, Santa Barbara, CA 93106 5080, USA
    Diabetes Technol Ther 9:438-50. 2007
    ..Thus, the identification of simple, accurate models plays an important role in the development of an artificial beta-cell...
  21. doi request reprint In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop
    Eyal Dassau
    Department of Chemical Engineering, Univ of California at Santa Barbara, California Biomolecular Science and Engineering Program, Univ of California at Santa Barbara, California Sansum Diabetes Research Institute, Santa Barbara, California, USA
    Diabetes Technol Ther 11:187-94. 2009
    ..Computer simulations usually involve only the controller software, leaving untested the hardware elements, including the critical communication interface between the controller and the glucose sensor and insulin pump...
  22. ncbi request reprint Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric
    Cesar C Palerm
    Department of Chemical Engineering, University of California Santa Barbara, Santa Barbara, CA 93106 5080, USA
    Diabetes Care 30:1131-6. 2007
    ..The dose is adjusted on the basis of a performance measure for the same meal on the previous day. We determine the best performance measure and tune the algorithm to match the recommendations of experienced physicians...
  23. ncbi request reprint Insulin pumps and their use in pregnancy
    Adrienne D Wollitzer
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Diabetes Technol Ther 12:S33-6. 2010
    ..Although only a small percentage of pregnant women with diabetes in the United States currently use insulin pumps, we believe that insulin pumps may represent a superior mode of insulin delivery for many women with diabetes in pregnancy...
  24. pmc Siphon effects on continuous subcutaneous insulin infusion pump delivery performance
    Howard C Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    J Diabetes Sci Technol 4:98-103. 2010
    ..The objective was to quantify hydrostatic effects on continuous subcutaneous insulin infusion (CSII) pumps during basal and bolus insulin delivery...
  25. doi request reprint Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus
    Howard Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Diabetes Technol Ther 14:997-1001. 2012
    ..This pilot trial was designed to determine if an optimal dose of Technosphere(®) insulin (TI) inhalation powder (MannKind Corp., Valencia, CA) could be used regardless of variation in meal carbohydrate (CHO) content...
  26. ncbi request reprint Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size
    Lois Jovanovic
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Clin Ther 26:1492-7. 2004
    ....
  27. ncbi request reprint New modalities in the treatment of pregnancies complicated by diabetes: drugs and devices
    Lironn Chitayat
    Sansum Diabetes Research Institute, Santa Barbara, CA 93105, USA
    Semin Fetal Neonatal Med 14:72-6. 2009
    ..Oral anti-diabetic agents are not recommended for use during pregnancy. Better control may be achieved with the incorporation of real-time glucose sensors and new insulin pumps with hopes of improving pregnancy outcome...
  28. ncbi request reprint Distribution of capillary glycated hemoglobin among adolescents of high school age
    David J Pettitt
    Sansum Diabetes Research Institute, Santa Barbara, CA 93105, USA
    Endocr Pract 14:529-34. 2008
    ..To report the distribution of glycated hemoglobin (hemoglobin A1c or A1C) in whole blood collected from a cohort of high school students with use of a capillary method...
  29. doi request reprint Definition, size of the problem, screening and diagnostic criteria: who should be screened, cost-effectiveness, and feasibility of screening
    Lois Jovanovic
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Int J Gynaecol Obstet 104:S17-9. 2009
    ....
  30. ncbi request reprint Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus
    Howard C Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Diabetes Technol Ther 9:509-15. 2007
    ..Our objective was to use continuous glucose monitoring to derive the optimal basal insulin infusion rates in adults with type 1 diabetes and using continuous subcutaneous insulin infusion (CSII) pumps...
  31. doi request reprint Using meal-based self-monitoring blood glucose (SMBG) data to guide dietary recommendations in patients with diabetes
    Lois Jovanovic
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Diabetes Educ 35:1023-30. 2009
    ..They provide immediate feedback to patients on the effect of foods and meals, thereby allowing appropriate food and medication adjustments to improve postprandial glycemic control...
  32. doi request reprint Approach to the patient with diabetes during pregnancy
    Jennifer Hone
    F A C E, Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, California 93105, USA
    J Clin Endocrinol Metab 95:3578-85. 2010
    ..Euglycemia before, during, and after all pregnancies complicated by diabetes results in the best opportunity for optimal outcomes for mother and infant...
  33. doi request reprint Management of type 2 diabetes and gestational diabetes in pregnancy
    Tara Boinpally
    Sansum Diabetes Research Institute, Santa Barbara, CA, USA
    Mt Sinai J Med 76:269-80. 2009
    ..From preconception care before pregnancy to medical treatment postpartum, it is essential that immediate care be taken to help mediate the effects of diabetes in pregnancy...
  34. ncbi request reprint Run-to-run control of meal-related insulin dosing
    Howard Zisser
    Sansum Diabetes Research Institute, University of California, Santa Barbara, California 93105, USA
    Diabetes Technol Ther 7:48-57. 2005
    ..This study was designed to determine if it was feasible to use a run-to-run algorithm to improve postprandial glucose concentrations in individuals with type 1 diabetes mellitus (T1DM)...
  35. doi request reprint Treatment with insulin and its analogs in pregnancies complicated by diabetes
    Lois Jovanovic
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Diabetes Care 30:S220-4. 2007
  36. ncbi request reprint Continuous glucose monitoring: is it helpful in pregnancy?
    Elizabeth Z Byrne
    Sansum Diabetes Research Institute, Santa Barbara, California 93105, USA
    Curr Diabetes Rev 4:223-6. 2008
    ..With the use of CGM, the complications of diabetic pregnancies first seen nearly two centuries ago will become a problem of the past...
  37. doi request reprint Pregnancy and diabetes management: advances and controversies
    Kristin Castorino
    Sansum Diabetes Research Institute, Santa Barbara, CA 93110, USA
    Clin Chem 57:221-30. 2011
    ..Early and accurate diagnosis of diabetes in pregnancy is necessary for optimizing maternal and fetal outcomes...
  38. ncbi request reprint Achieving euglycaemia in women with gestational diabetes mellitus: current options for screening, diagnosis and treatment
    Lois Jovanovic
    Sansum Medical Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Drugs 64:1401-17. 2004
    ..There is now some evidence that insulin lispro, other insulin analogues and oral antihyperglycaemic drugs may be beneficial in gestational diabetes, and more data on these agents are awaited with interest...
  39. ncbi request reprint Insulin analogues in the treatment of diabetes in pregnancy
    Charanpal Singh
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Obstet Gynecol Clin North Am 34:275-91, ix. 2007
    ..This article also reviews the literature on the insulin analog during pregnancy and presents the authors' opinion as to the safety and efficacy of insulin analog treatment for the pregnant diabetic woman...
  40. pmc Advances in diabetes for the millennium: diabetes in women
    Lois Jovanovic
    Sansum Research Foundation, Santa Barbara, California, USA
    MedGenMed 6:3. 2004
    ..This review outlines the rationale of programs of normalized glycemia for diabetic women and suggests strategies to achieve success...
  41. ncbi request reprint Nutrition and pregnancy: the link between dietary intake and diabetes
    Lois Jovanovic
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Curr Diab Rep 4:266-72. 2004
    ..The challenge for clinicians is to provide nutritional information based on scientific evidence that facilitates the normalization of fetal nutrition, and thus minimize the risk that the child will develop diabetes...
  42. doi request reprint Low birth weight as a risk factor for gestational diabetes, diabetes, and impaired glucose tolerance during pregnancy
    David J Pettitt
    Sansum Diabetes Research Institute, 2219 Bath St, Santa Barbara, CA 93105, USA
    Diabetes Care 30:S147-9. 2007
  43. ncbi request reprint Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes
    Lois Jovanovic
    Sansum Diabetes Research Institute, Santa Barbara, California, USA
    Endocr Pract 10:40-5. 2004
    ..To present protocols for maintaining normoglycemia during labor and delivery in order to achieve optimal outcomes of pregnancy in women with diabetes...
  44. pmc Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy
    Lois Jovanovic
    Sansum Diabetes Research Institute, Santa Barbara, California, USA
    Diabetes Care 34:53-4. 2011
    ..No guidelines for A1C measurement exist for women with gestational diabetes mellitus (GDM). The aim of this study was to document the rate of A1C decline in women with GDM...
  45. ncbi request reprint Glycohemoglobin (A1C) distribution in school children: results from a school-based screening program
    David J Pettitt
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Diabetes Res Clin Pract 65:45-9. 2004
    ..To establish the normal distribution for glycohemoglobin (A1C) in sixth and seventh grade children and to assess the practicality of a school-based fingerstick screening program...
  46. ncbi request reprint The fidgety fetus hypothesis: fetal activity is an additional variable in determining birth weight of offspring of women with diabetes
    Howard Zisser
    Sansum Diabetes Research Institute, Santa Barbara, California, USA
    Diabetes Care 29:63-7. 2006
    ..To determine whether some offspring of women with diabetes are intrinsically more active than others in utero and whether those who are active are able to normalize their birth weight despite maternal hyperglycemia...
  47. ncbi request reprint Decreasing the risk of diabetic retinopathy in a study of case management: the California Medi-Cal Type 2 Diabetes Study
    David J Pettitt
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Diabetes Care 28:2819-22. 2005
    ..This study tested whether intensive diabetes case management could prevent or delay diabetic retinopathy in patients with established type 2 diabetes...
  48. ncbi request reprint The vicious cycle of diabetes and pregnancy
    David J Pettitt
    Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, CA 93105, USA
    Curr Diab Rep 7:295-7. 2007
    ..Solutions need to be found to break this cycle by preventing diabetes or delaying its onset until later in life and by normalizing glucose regulation during pregnancy...
  49. ncbi request reprint Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus
    David J Pettitt
    Sansum Medical Research Institute, Santa Barbara, California Novo Nordisk Pharmaceuticals, Inc, Princeton, New Jersey, USA
    Diabetes Care 26:183-6. 2003
    ..To assess the short-term efficacy of insulin aspart in comparison with regular human insulin in women with gestational diabetes mellitus (GDM) during standardized meal tests...
  50. doi request reprint Oral anti-CD3 monoclonal antibody delays diabetes in non-obese diabetic (NOD) mice: effects on pregnancy and offspring--a preliminary report
    Wendy C Bevier
    Sansum Diabetes Research Institute, Santa Barbara, CA 93105, USA
    Diabetes Metab Res Rev 27:480-7. 2011
    ..The objective was to observe the effect of oral anti-CD3 monoclonal antibody (mAb) on non-obese diabetic mice, pregnancy, and offspring...
  51. ncbi request reprint Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse
    Illani Atwater
    Sansum Medical Research Institute, Santa Barbara, California 93105, USA
    Ann Clin Lab Sci 32:87-92. 2002
    ..Prolactin alone had a partial protective effect. The results have implications for prevention of type 1 diabetes and for immune suppression in patients receiving islet cell transplantation...
  52. ncbi request reprint Improving outcomes in pregnant women with type 1 diabetes
    Moshe Hod
    Diabetes Care 30:e62. 2007
  53. ncbi request reprint Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker
    John B Buse
    Divisions of Endocrinology and of General Medicine and Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Diabetes Technol Ther 5:355-63. 2003
    ..The behavior of this analyte is different from all others used in the management of diabetes, creating potential opportunities for its use in clinical practice...
  54. ncbi request reprint Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus
    Yariv Yogev
    Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Obstet Gynecol 101:633-8. 2003
    ..To compare the daily glycemic profile reflected by continuous and intermittent blood glucose monitoring in pregnant women with type 1 diabetes and to compare the treatment protocols based on the two monitoring methods...
  55. ncbi request reprint A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States
    John B Buse
    Diabetes Care Center and Division of General Medicine, University of North Carolina School of Medicine, 5039 Old Clinic Building, CB 7110, Chapel Hill, NC 27599 7110, USA
    J Clin Epidemiol 56:164-70. 2003
    ..An increased risk of developing diabetes compared with the AdvancePCS general patient population was observed during treatment with conventional or atypical antipsychotics...
  56. ncbi request reprint Point: yes, it is necessary to rely entirely on glycemic values for the insulin treatment of all gestational diabetic women
    Lois Jovanovic
    Diabetes Care 26:946-7. 2003
  57. ncbi request reprint An improved PID switching control strategy for type 1 diabetes
    Gianni Marchetti
    Department of Chemical Engineering Principles and Practice, Universita di Padova, Padova, Italy
    Conf Proc IEEE Eng Med Biol Soc 1:5041-4. 2006
    ....
  58. ncbi request reprint Never say never in medicine: confessions of an old dog
    Lois Jovanovic
    Diabetes Care 27:610-2. 2004
  59. doi request reprint Weight gain and gestational diabetes mellitus is a sensitive issue
    Wendy C Bevier
    Diabetes Care 31:e1. 2008
  60. doi request reprint An improved PID switching control strategy for type 1 diabetes
    Gianni Marchetti
    Dipartimento di Principi e Impianti di Ingegneria Chimica, Universita di Padova, 35131 Padova, Italy
    IEEE Trans Biomed Eng 55:857-65. 2008
    ....
  61. ncbi request reprint Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus
    Camelia Owens
    Department of Chemical Engineering, University of Delaware, Newark 19716, USA
    IEEE Trans Biomed Eng 53:996-1005. 2006
    ..Along with this, the insulin sensitivity of the virtual patient model is varied. The algorithm is robust for differences in insulin sensitivity less than +/- 50% of the nominal value...
  62. ncbi request reprint Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 1775 N Ursula St, A140, Aurora, Colorado 80010, USA
    Diabetes Care 29:44-50. 2006
    ..In this study we evaluated the accuracy, safety, and clinical effectiveness of a continuous glucose-sensing device...
  63. ncbi request reprint Successful pregnancy in women with type 1 diabetes: from preconception through postpartum care
    Lois Jovanovic
    Keck School of Medicine, University of Southern California at Los Angeles, Los Angeles, CA, USA
    Endocrinol Metab Clin North Am 35:79-97, vi. 2006
  64. ncbi request reprint Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome
    Rachele Berria
    Division of Diabetes, Department of Medicine Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Clin Pharmacol Ther 80:105-14. 2006
    ..Further studies are necessary to evaluate whether the same scenario is applicable to normoandrogenic women and individuals with type 2 diabetes mellitus...
  65. ncbi request reprint Proposal for the reconsideration of the definition of gestational diabetes
    Yasue Omori
    Diabetes Care 28:2592-3. 2005
  66. ncbi request reprint Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes
    Lois Jovanovic
    University of Washington, 325 Ninth Ave, Box 359720, Seattle, WA 98104, USA
    Diabetes Care 28:1113-7. 2005
    ..To test this hypothesis, we examined relationships of proximate measures of prior glycemia, glycated protein and fructosamine, to pregnancy loss...
  67. ncbi request reprint OmniPod Insulin Management System: patient perceptions, preference, and glycemic control
    Howard Zisser
    Diabetes Care 29:2175. 2006
  68. ncbi request reprint Point: Oral hypoglycemic agents should not be used to treat diabetic pregnant women
    Lois Jovanovic
    Diabetes Care 30:2976-9. 2007
  69. ncbi request reprint Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, 1775 N Ursula St A140, Aurora, CO 80010, USA
    Diabetes Care 29:2644-9. 2006
    ..In this study, we evaluated the safety and efficacy of 7-day transcutaneous, real-time, continuous glucose monitoring (CGM) in subjects with insulin-requiring diabetes...
  70. ncbi request reprint Metformin in pregnancy: its time has not yet come
    Florence M Brown
    Diabetes Care 29:485-6. 2006